12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Arresto BioSciences, Gilead deal

Gilead will acquire Arresto for $225 million in cash, plus potential payments based on sales levels. Gilead said the deal would add to its pipeline in fibrotic...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >